Please wait...
About This Project
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are in urgent demand across the entire world as the Coronavirus Disease 2019 (COVID-19) pandemic continues to interrupt the well-being of human life. Without clinical therapeutics available for any of the human coronaviruses, a key starting point is to focus on target-based high-throughput screening (HTS) to reveal potent anti-SARS-CoV-2 hit-to-leads that are safe to human cells.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Can immune cells prevent 3D printed blood vessels from falling apart?
Mass production of cells is limited by nutrient delivery. 3D printing of hydrogel has enabled the printing...
Can we grow a supply of red blood cells by differentiating stem cells to replace donor blood?
Stem cells have progressed into a common treatment for various diseases including cancers, immune disorders...